TTY Biopharm Co Ltd (4105) — Free Cash Flow Generation Index
TTY Biopharm Co Ltd (4105) has a Free Cash Flow Generation Index of 0.96x as of December 2025. Free cash flow of NT$744.17 Million represents 1% of operating cash flow (NT$778.89 Million). See how liquid is TTY Biopharm Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
TTY Biopharm Co Ltd Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for TTY Biopharm Co Ltd across 9 annual periods. Explore cash flow to debt ratio of TTY Biopharm Co Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for TTY Biopharm Co Ltd (2017–2025)
Year-by-year Free Cash Flow Generation Index for TTY Biopharm Co Ltd. For the full company profile including market capitalisation, see how much is TTY Biopharm Co Ltd worth.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | NT$1.61 Billion | NT$1.76 Billion | NT$150.83 Million | ▲ +1.5% |
| 2024 | 0.90x | NT$1.22 Billion | NT$1.35 Billion | NT$134.29 Million | ▼ -0.9% |
| 2023 | 0.91x | NT$985.73 Million | NT$1.09 Billion | NT$99.58 Million | ▲ +2.0% |
| 2022 | 0.89x | NT$1.10 Billion | NT$1.24 Billion | NT$135.50 Million | ▼ -5.4% |
| 2021 | 0.94x | NT$1.18 Billion | NT$1.26 Billion | NT$74.15 Million | ▲ +43.8% |
| 2020 | 0.65x | NT$344.49 Million | NT$526.35 Million | NT$181.86 Million | ▼ -30.5% |
| 2019 | 0.94x | NT$1.14 Billion | NT$1.21 Billion | NT$69.86 Million | ▲ +2.4% |
| 2018 | 0.92x | NT$987.49 Million | NT$1.07 Billion | NT$74.09 Million | ▲ +1.9% |
| 2017 | 0.90x | NT$899.03 Million | NT$996.52 Million | NT$96.79 Million | — |